Carroll Financial Associates, Inc. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 214 filers reported holding PDL BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
Carroll Financial Associates, Inc. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q2 2019$0
-100.0%
19
-97.4%
0.00%
-100.0%
Q3 2015$3,000
-40.0%
737
+2.8%
0.00%0.0%
Q2 2015$5,0000.0%717
+2.4%
0.00%
-50.0%
Q1 2015$5,0000.0%7000.0%0.00%
-33.3%
Q4 2014$5,0000.0%7000.0%0.00%
+50.0%
Q3 2014$5,000
-28.6%
7000.0%0.00%0.0%
Q2 2014$7,000
+16.7%
7000.0%0.00%0.0%
Q1 2014$6,000
+20.0%
7000.0%0.00%0.0%
Q4 2013$5,0007000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2015
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders